A new drug substance found fail to meet specification for
an unknown Impurity during stability study(Specific
change),how would further proceed?
Answer Posted / chinna
if the sample failed in accelerated condition we go for long term storage condition.if it fails in long term stability we go for OOS and give to retest/Expiry as per ICH guideline
Is This Answer Correct ? | 1 Yes | 0 No |
Post New Answer View All Answers
Loss of linearity in tkn analysis, possible reasons?
What if impurity area in control sample coming more as compared to LOQ level of impurity ?
What is the diffrence in japan mkt requirement in analytical method validation over US?
AT WHAT CONDITIONS WILL YOU ANALYSE A SAMPLE,WHICH ARE PRESERVED AT OTHER THAN THE AMBIENT CONDITIONS?(ie COLD STORAGE SAMPLES BELOW 20* CENTIGRADE?
how to set sample and standard concentration in RS method?
how will you do the prep for unstable componds?
why require to add enzymes in capsules dissolution only? is it require to tablet also?
how decide the clining method and cleaning method validation require for this perticular products?
Which are the diffrent grades of api in pharma?
what is different when impergnated silica plates are used in separation of azo dyes using column chromatography?
1.What is the difference between method validation and method verification 2.Which guidelines proposed to method transfer
if peak get problamatic then what require to do?
How to set analytical specification for combination products?
Why irmoisture balance is used for corrugated box moisture testing
please explain about aluminium hydroxide assay